Neurotrophins are a group of proteins that play a critical role in the health and function of our nervous system. They are ...

Peptide Therapeutics MarketThe global peptide therapeutics market is on a strong growth trajectory, with sales projected to ...

The global leukemia therapeutics treatment market has seen considerable growth, progressing from USD 14,504.8 million in 2022 to USD 15,246.7 million in 2023. With a projected compound annual growth ...

The veterinary auto-immune therapeutics market is projected to grow at a 5.3% CAGR, reaching $71.7 billion by 2033.

( MENAFN - GlobeNewsWire - Nasdaq) Germany's peptide therapeutics market is set to grow at a 3.3% CAGR from 2024 to 2034, driven by strong healthcare systems, favorable policies, and the rise of ...

RAPT also raises $150M in a private placement, with shares surging premarket. RAPT Therapeutics, Inc. RAPT shares are trading higher after the company disclosed a partnership with Shanghai ...

(RTTNews) - Cara Therapeutics, Inc. (CARA), Wednesday announced that the company has entered into a merger agreement with Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--SiteOne Therapeutics, Inc., a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough, and other ...

Morgan Stanley analyst Michael Ulz maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report) yesterday and set a price target of $15.00. Discover top-rated stocks from highly ...

Credit: mToa55 via Shutterstock. Viridian Therapeutics’s stock has jumped after a Phase III trial of veligrotug met all endpoints and was well tolerated in patients with chronic thyroid eye disease ...

Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped three new research collaborations focusing on autoimmune diseases.